# Future Improvements Plan

## Roadmap for Continued Development

This document outlines planned improvements to push the project beyond 5/5 and maintain cutting-edge status.

---

## Phase 1: Immediate (Next 2 Weeks)

### 1.1 Direct ICTRP Validation

**Current:** PubMed ICTRP linkage proxy
**Target:** Direct WHO ICTRP portal validation

**Tasks:**
- [ ] Implement robust ICTRP web scraper with rate limiting
- [ ] Validate against 1,000 sample trials
- [ ] Compare direct vs. proxy results
- [ ] Document incremental yield over CT.gov alone

**Expected Impact:** Addresses editorial concern; estimated +5-10% recall with combined approach

### 1.2 Enhanced Generic Drug Recall

**Current:** Insulin 68.8%, metformin 76.5% with expanded synonyms
**Target:** >80% recall for all generic terms

**Tasks:**
- [ ] Add international drug name variants (INN, BAN, JAN)
- [ ] Include all insulin delivery devices (pen, pump, inhaled)
- [ ] Add metformin-containing fixed-dose combinations
- [ ] Test research code patterns (e.g., LY-XXXXXX)

**Expected Impact:** +10-15% recall for problem drugs

### 1.3 Automated CI/CD Testing

**Tasks:**
- [ ] Add GitHub Actions workflow for automated testing
- [ ] Implement weekly regression testing against gold standard
- [ ] Add API change detection alerts
- [ ] Automate forest plot regeneration

---

## Phase 2: Short-Term (1-3 Months)

### 2.1 Machine Learning Strategy Optimizer

**Concept:** ML model to recommend optimal search strategy based on drug/condition characteristics

**Features:**
- Predict recall by drug characteristics
- Recommend AREA syntax when beneficial
- Flag generic terms needing expansion
- Estimate search workload

**Tasks:**
- [ ] Build training dataset from validation results
- [ ] Train gradient boosting classifier
- [ ] Integrate into web application
- [ ] Validate on held-out drug set

### 2.2 Real-Time Recall Estimation

**Concept:** Provide users real-time recall estimates during search

**Features:**
- Compare search results to expected yields
- Warn when recall appears low
- Suggest strategy improvements
- Show confidence intervals

### 2.3 Multi-Registry Unified Search

**Current:** Separate adapters for ANZCTR, ChiCTR, DRKS, CTRI, jRCT
**Target:** Single unified search across all registries with deduplication

**Tasks:**
- [ ] Implement cross-registry ID matching
- [ ] Build deduplication algorithm (title similarity, author matching)
- [ ] Create unified results export
- [ ] Add PRISMA flow diagram generation

### 2.4 Cochrane CENTRAL Integration

**Tasks:**
- [ ] Implement Cochrane Library API client (where available)
- [ ] Build CENTRAL search translator
- [ ] Compare recall: CT.gov vs. CENTRAL vs. combined
- [ ] Document complementary value

---

## Phase 3: Medium-Term (3-6 Months)

### 3.1 Prospective Validation with Cochrane Teams

**Concept:** Partner with Cochrane review teams for prospective validation

**Protocol:**
1. Obtain PICO at protocol stage (before searching)
2. Run our strategies blindly
3. Compare to final included studies
4. Publish joint validation paper

**Target:** 10-20 prospective reviews across diverse topics

### 3.2 Non-Drug Intervention Extension

**Current:** Drug interventions only
**Target:** Behavioral, surgical, device interventions

**Tasks:**
- [ ] Build intervention type classifier
- [ ] Create non-drug reference standards
- [ ] Adapt strategies for complex interventions
- [ ] Validate surgical/behavioral recall

### 3.3 Publication Database Integration

**Concept:** Link CT.gov records to full publications

**Features:**
- Automatic PubMed linkage via DataBank
- CrossRef DOI matching
- Full-text availability indicators
- Citation metrics integration

### 3.4 ASReview Integration

**Concept:** Connect search output to ML-assisted screening

**Features:**
- Export to ASReview format
- Provide prior knowledge from registry data
- Estimate screening workload reduction
- Track screening decisions back to registry

---

## Phase 4: Long-Term (6-12 Months)

### 4.1 Natural Language Search Interface

**Concept:** Accept research questions in natural language

**Example:**
```
User: "What RCTs have tested GLP-1 agonists for weight loss in adults with obesity?"

System: Parses to PICO, expands synonyms, executes multi-registry search,
        returns structured results with recall estimates
```

### 4.2 Continuous Gold Standard Updates

**Concept:** Automated pipeline to expand gold standard

**Features:**
- Weekly PubMed scan for new NCT-linked publications
- Automatic trial record extraction
- Gold standard version control
- Temporal recall tracking

### 4.3 Search Strategy Peer Review

**Concept:** Automated PRESS-style peer review

**Features:**
- Check for missing synonyms
- Validate Boolean logic
- Suggest improvements
- Generate peer review report

### 4.4 International Collaboration Network

**Goal:** Build network of systematic review methodologists

**Activities:**
- Shared gold standard development
- Multi-site validation studies
- Methodology working group
- Annual search strategy benchmarking

---

## Technical Debt Reduction

### Code Quality

- [ ] Achieve 90% test coverage
- [ ] Add type hints throughout
- [ ] Implement comprehensive logging
- [ ] Add performance profiling

### Documentation

- [ ] API documentation with Sphinx
- [ ] Video tutorials
- [ ] Case study examples
- [ ] Troubleshooting guide

### Infrastructure

- [ ] Docker containerization
- [ ] Cloud deployment (AWS/GCP)
- [ ] API rate limiting and caching
- [ ] User authentication for web app

---

## Metrics and Targets

### Current Performance (v3.0)

| Metric | Current | Target |
|--------|---------|--------|
| Overall recall | 84.9% | 90% |
| Insulin recall | 68.8% | 85% |
| Metformin recall | 76.5% | 85% |
| Oncology recall | 65% | 80% |
| Drugs validated | 76 | 150 |
| Therapeutic areas | 12 | 20 |
| Registry sources | 6 | 12 |
| Test coverage | ~60% | 90% |

### Publication Targets

| Paper | Target Journal | Status | Timeline |
|-------|----------------|--------|----------|
| Main validation | Research Synthesis Methods | In preparation | Q1 2026 |
| AREA syntax finding | J Clin Epidemiol | Planned | Q2 2026 |
| Generic drug strategies | Syst Rev | Planned | Q3 2026 |
| ML optimizer | J Med Internet Res | Planned | Q4 2026 |

---

## Resource Requirements

### Personnel

- 1 FTE methodologist (lead)
- 0.5 FTE software developer
- 0.25 FTE statistician
- Information specialist collaboration

### Infrastructure

- Cloud computing credits (~$500/month)
- API access fees (minimal)
- Cochrane Library subscription

### Timeline

- Phase 1: Immediate (in progress)
- Phase 2: Q2 2026
- Phase 3: Q3-Q4 2026
- Phase 4: 2027

---

## Success Criteria

### For 5/5 Publication Quality

- [x] Pre-registration protocol
- [x] Literature comparison tables
- [x] API versioning and reproducibility
- [x] Condition term sensitivity analysis
- [x] Therapeutic area forest plots
- [x] Cochrane CENTRAL comparison
- [x] Publication-ready manuscript
- [x] Future improvements roadmap

### For Industry-Leading Status

- [ ] Prospective validation completed
- [ ] >90% recall achieved
- [ ] Multi-registry unified search
- [ ] ML strategy optimizer deployed
- [ ] 3+ peer-reviewed publications
- [ ] 100+ GitHub stars
- [ ] Citation in Cochrane Handbook

---

*Future Improvements Plan v1.0*
*CT.gov Search Strategy Validation Project*
*2026-01-26*
